Williams N M, Preece A, Spurlock G, Norton N, Williams H J, Zammit S, O'Donovan M C, Owen M J
Department of Psychological Medicine, University of Wales College of Medicine, Heath Park, Cardiff, Wales CF14 4XN, UK.
Mol Psychiatry. 2003 May;8(5):485-7. doi: 10.1038/sj.mp.4001348.
Recently, it has been reported that genetic variants around the gene neuregulin 1 are associated with schizophrenia in an Icelandic sample. Of particular interest was the presence of a single-risk haplotype that was significantly over-represented in schizophrenic individuals compared to controls (15.4 : 7.5%, P=6.7 x 10(-6)). We have attempted to replicate this result in our large collection of 573 schizophrenia cases and 618 controls. We found that the risk haplotype was more common in cases than controls (9.5 : 7.5%; P=0.04), and especially in our subset of 141 cases with a family history of schizophrenia (11.6%; P=0.019). Our results therefore replicate the Icelandic findings in an out-bred Northern European population, although they suggest that the risk conferred by the haplotype is small.
最近,有报道称在冰岛样本中,神经调节蛋白1基因周围的遗传变异与精神分裂症有关。特别令人感兴趣的是,与对照组相比,一种单一风险单倍型在精神分裂症患者中显著过度出现(15.4 : 7.5%,P = 6.7×10⁻⁶)。我们试图在我们收集的573例精神分裂症病例和618例对照的大样本中重复这一结果。我们发现风险单倍型在病例组中比对照组更常见(9.5 : 7.5%;P = 0.04),特别是在我们有精神分裂症家族史的141例病例子集中(11.6%;P = 0.019)。因此,我们的结果在一个非近亲繁殖的北欧人群中重复了冰岛的研究结果,尽管这表明该单倍型带来的风险很小。